COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse

grdirks
Apr 11, 2025
1 min read

Updated: Feb 10

COOLOGICS, a clinical-stage medical device company, has announced the commencement of new, larger multi-center, open-label clinical trials for its innovative product, Vlisse. These trials will begin this month with the objective of gathering sufficient data to secure FDA clearance for the device.

Recent Posts

See All

Florida Angels Join $4.7M Hyperspectral Imaging Round, AI Writes up to One-Third of Microsoft's Code, and Why Clarity is Kindness

Coologics | Drug-free vaginal infection treatment Participating Groups: Ohio State Early Investor Network , Illini Angels Coologics is developing a drug-free intravaginal cooling device called Vlisse

Coologics Secures $3M for Drug-Free Vaginal Infection Treatment Device

Coologics , a US-based clinical-stage medical device company, has successfully closed an oversubscribed seed funding round, raising over $3 million for its innovative vaginal infection treatment devic

Cleveland women's healthtech startup secures $3M, doubling initial target

A Cleveland-based clinical-stage medical device company announced it has closed an oversubscribed $3 million seed funding round, doubling the initial $1.5 million target. Read more.

Comments

Vlisse™ is a Class I Device in the European Union CE Mark Pending and a FDA Class II device pending FDA clearance.